Загрузка...
Maintenance Therapy for First-Line Metastatic Colorectal Cancer: Activity and Sustainability
Results of a study, published in this issue of The Oncologist, comparing capecitabine and oxaliplatin plus bevacizumab with the same regimen for only six cycles followed by bevacizumab monotherapy in metastatic colorectal cancer patients are examined.
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AlphaMed Press
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3267828/ https://ncbi.nlm.nih.gov/pubmed/22234629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0358 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|